US de­clares mon­key­pox a na­tion­al health emer­gency, as new drug­mak­ers con­sid­er en­ter­ing vac­cine race

Ris­ing mon­key­pox cas­es have put the US on high alert as it an­nounces a na­tion­al health emer­gency, which grants the gov­ern­ment more pow­er in its re­sponse.

The news comes as Bavar­i­an Nordic con­tin­ues to fill or­ders for its Jyn­neos vac­cine and oth­er com­pa­nies – in­clud­ing Mod­er­na – con­sid­er jump­ing in­to the vac­cine race. Mean­while, the New York Times re­ports that the US has al­lowed around 20 mil­lion dos­es of small­pox vac­cine in its stock­pile to ex­pire.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER